Journal of Clinical Oncology and Cancer Research  ( ISSN : 2996-5543 )

Journal of Clinical Oncology and Cancer Research

ISSN: 2996-5543

Journal of Clinical Oncology and Cancer Research is a leading peer-reviewed, open-access publication dedicated to showcasing advanced research articles in both experimental and clinical oncology. With a strong emphasis on multidisciplinary collaboration, the journal serves as a vital platform for the rapid exchange of cutting-edge research and information among clinicians, doctors, and researchers worldwide. By providing up-to-date insights into cancer and related fields, the journal plays a crucial role in disseminating knowledge and driving progress in the fight against cancer.

The scope of the journal is extensive, covering a wide range of key aspects within the field of oncology. This includes clinical considerations of cancer, cancer pathobiology, cancer diagnosis, diagnostic tools and techniques, critical events in cancer progression, therapeutic approaches targeting oncogenes, medical interpretation of oncological data, and the psychological and physical aspects of cancer treatment. Furthermore, the journal explores recent advances in cancer diagnosis and treatment, making it an indispensable resource for professionals working in the field.

Manuscripts are invited across diverse areas of research, including cancer chemotherapy, benign tumors, pediatric oncology, molecular biology, radiation oncology, metastasis, angiogenesis, apoptosis, tumor markers, radiotherapy and biotherapy, clinical trials in oncology, chemotherapy, cancer nanotechnology, and developments in cancer prevention. By providing a robust platform for the dissemination of high-quality research findings, the journal significantly contributes to advancing our understanding and treatment of cancer.

The Journal of Clinical Oncology and Cancer Research warmly welcomes a variety of submission types, including research papers, review articles, case reports, short communications, mini-reviews, opinions, and letters to the editors. Through these diverse formats, the journal fosters a dynamic and collaborative environment for sharing insights and discoveries, ultimately driving progress towards improved cancer outcomes.

Track Your Paper: Our Editorial Tracking System will guide you through the stages from the moment your article has been submitted until it is published. Every step is described and will let you know whether action is required.

Quality Publication: We have our own standards and criteria for classification. Using leading-edge technologies, we aim to make publishing worldwide safer, plagiarism-free, and approachable to researchers. We are committed to maintaining optimal quality standards across all of our publications. From editing to layout to distribution, we strive to exceed expectations at every stage of the process.

No Profit-Oriented Goal Setting, No Hidden Clues: Our non-profit collaboration is driven by the desire to accelerate scientific discoveries and make scientific content open and available to a wider readership, gain media attention, and demonstrate professional achievement through publication.

Rapid and Fast Publication: All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other ways helps to complete the article processing within the promised timeline.

Submission Process: Authors may submit the manuscript either online or as an email attachment to

Latest Articles :

Research Article - Volume 1, Issue 1 (2023)
Perspectives on Antihypertensive Drugs and Brain Autoregulation: A Chronicle of Views and Pathophysiological Insights
 Hebert Allan   MacLean Green   Hugeness Greiver   Meyerowitz Katz
Research Article - Volume 1, Issue 1 (2023)
Multiple Myeloma: Bortezomib, Lenalidomide, and Dexamethasone Intensol
 López Anglada   Juan Bargay   Isidro Jarque   Ana González   Bruno Paiva